Submit your email to push it up the queue
Research And Diagnostic Systems, Inc. (R&D Systems), headquartered in the United States, is a leading provider in the biotechnology industry, specialising in the development of high-quality research and diagnostic tools. Founded in 1977, the company has established a strong presence in major operational regions across North America and Europe. R&D Systems is renowned for its extensive range of products, including antibodies, proteins, and assay kits, which are pivotal for scientific research and clinical diagnostics. Their commitment to innovation and quality has positioned them as a trusted partner for researchers worldwide. Notable achievements include numerous collaborations with academic institutions and contributions to significant advancements in life sciences. With a focus on precision and reliability, R&D Systems continues to support the evolving needs of the scientific community.
How does Research And Diagnostic Systems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Research And Diagnostic Systems, Inc.'s score of 42 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research And Diagnostic Systems, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Bio-Techne Corporation, which may influence its climate commitments and performance metrics. As part of its corporate family, Research And Diagnostic Systems, Inc. inherits climate initiatives and targets from Bio-Techne Corporation. However, there are no documented reduction targets or specific climate pledges available for this subsidiary. The lack of emissions data and reduction initiatives suggests that the company may still be in the early stages of developing its climate strategy. In the context of the industry, it is essential for organisations like Research And Diagnostic Systems, Inc. to establish clear carbon reduction goals and report emissions transparently to align with global climate standards and expectations.
Access structured emissions data, company-specific emission factors, and source documents
2021 | 2022 | 2023 | |
---|---|---|---|
Scope 1 | 2,684,000 | 0,000,000 | 0,000,000 |
Scope 2 | 12,694,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Research And Diagnostic Systems, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.